Belarus National Registration Window Ends 31 December 2027

1. Key takeaways

The window for filing medical device registration applications under the Belarusian national procedure is now counting down. According to the statement made by the Belarusian Minister of Health in the House of Representatives, the transition period is extended to 31 December 2027, and the circulation within the union of devices registered under member-state legislation also continues until 31 December 2027 (conditional on the registration documents remaining valid). Thereafter, new registrations will in principle move to union rules.

2. Legal basis

3. Expert insights

Insight 1: the original date was 1 January 2026; it is now 31 December 2027 — a two-year extension. Under the original arrangement of the union agreement, from 2026-01-01 the registration of medical devices within the union was to proceed only under union law. The protocol pushed this date back. For companies, this means a national window they may have assumed was already closed has reopened — but the reopening is finite.

Insight 2: circulation continuation and application acceptance are two different cutoff dimensions. The Minister’s statement contains three time elements at once: the transition period itself (until 2027-12-31), the retained period for accepting applications under member-state legislation (until 2028-12-31), and the continuation of circulation for devices registered under member-state legislation (until 2027-12-31, conditional on the registration documents remaining valid). The three dimensions do not coincide, and companies easily misread still possible to apply as still possible to sell forever.

Insight 3: the stated reason for the extension is avoiding device shortages. The Minister stated expressly that member states shared the view that the established time limit was insufficient to complete the transition to union registration and to abandon state registration entirely, and that the protocol was signed to avert the threat of shortages of registered medical devices in the union member states. This indicates the extension is a supply-security-oriented temporary arrangement, not an institutional rollback — the probability of the window closing again is higher than the probability of another extension.

Insight 4: the national procedure is still being optimized within the window. № 211 took effect on 2026-05-01, compressing preliminary technical work to 90 calendar days and closing the list of such work. This shows Belarus is still improving the predictability of its national procedure during the window rather than letting it wither on the vine. Filing a national application within the window may offer better value than expected.

Insight 5: the countdown has two audiences — the project pipeline and the existing portfolio. For new projects, the 2027-12-31 baseline governs when a national filing must start. For the existing portfolio, the same date governs how long products registered under member-state legislation continue to circulate, so the portfolio should be sorted now into items that will need a union registration and items that can run out their validity within the window. Sorting early turns the cutoff from a deadline shock into a manageable sequencing exercise, and it also identifies which certificate renewals are no longer worth pursuing.

4. Practical recommendations

1. Build a countdown dashboard for the window. Using 2027-12-31 as the baseline deadline, work backward through the time needed for dossier preparation, preliminary technical work and certificate issuance, and mark the latest start date.
2. Manage the validity of registration documents as the precondition of circulation continuation. The continuation of circulation for devices registered under member-state legislation is conditional on the registration documents remaining valid; certificates that expire, are suspended or are revoked do not benefit from the continuation.
3. Prepare the union route in parallel. While filing a national application within the window, companies with multi-market plans should advance union-route preparation in parallel, to avoid starting from zero once the window closes.
4. Do not rely on another extension. Schedule on the most conservative assumption and treat a further extension as upside, not as the plan.

5. Verification checklist

• □ Countdown dashboard built on the 2027-12-31 baseline
• □ The three dimensions — transition period, application acceptance period, circulation continuation — distinguished
• □ Validity of registration documents managed as the precondition of circulation continuation
• □ Union-route dossier preparation advanced in parallel
• □ Schedule does not depend on an assumption of another extension

Regulatory information verified as of 2026-10-30.

In the Eurasian Economic Union market, GRZAN concentrates its core capabilities in three areas. First, distinguishing between the union-wide registration route and each member state’s national registration route — their applicable conditions and remaining time windows. The national registration procedure of Belarus has been fully replaced by Council of Ministers Resolution No. 211 of 28 April 2026 (state registration number 6-1/55925, effective 1 May 2026), which caps the total duration of preliminary technical work at 90 calendar days, keeps the list of that work closed and prohibits the organizing body from expanding it, while the window for filing applications under the national procedure has 31 December 2027 as its key date, so the choice of route must be made in step with the time window. Second, local authorized representative services: GRZAN may act as the manufacturer’s statutory representative in Belarus, undertaking registration submissions, responses to technical queries, changes to the registration dossier and post-market reporting obligations, and it has updated its liaison arrangements after Council of Ministers Resolution No. 378 of 27 July 2026 (effective 30 July 2026) transferred the adverse-event functions to the State Institution State Medical Products Supervision (Gosfarmnadzor). Third, quality system and testing support: GRZAN assists in establishing a quality management system that meets ISO 13485 requirements and in organizing technical documentation for the chosen route — the national route follows the annexes to Ministry of Health Resolution No. 55, and the union route follows Decision No. 46 of the Board of the Eurasian Economic Commission.

Business inquiries: info@grzanglobal.com